Under the new NSW Health Smoke-free Health Care Policy, the smoke-free status of public hospital campuses has been reaffirmed and all clinical staff are required to provide routine brief interventions for all smoking patients.
The policy creates a unique opportunity to assist smokers to quit permanently in a supportive environment when motivation to quit is high. Smoking remains the leading cause of preventable death and disability in New South Wales (NSW).
Counselling beginning in hospital and continuing for at least 1 month after discharge significantly increases quit rates. Smoking can be addressed using the 5As model, which includes asking about smoking, assessing readiness to change and nicotine dependence, advising all smokers to quit, assisting smokers to quit and arranging follow-up. Postdischarge support is a vital ingredient for long-term success and should be arranged during the hospital stay.
Nicotine replacement therapy (NRT) should be offered to all nicotine-dependent smokers soon after admission. NRT helps manage cravings and nicotine withdrawal symptoms and significantly increases quit rates. Most smokers commence NRT on a nicotine patch, with an oral form of NRT added as required. It is important to give patients detailed instructions on the correct use of NRT and to ensure an adequate dose is taken to relieve symptoms. NRT is well tolerated and can be used perioperatively, during pregnancy and in patients with cardiovascular disease.
Blood levels of certain drugs rise within several days after smoking cessation, so dose reductions may be required. Drugs with a narrow therapeutic index such as clozapine, olanzapine, warfarin and theophylline are of special importance.
NSW Health has recently revised and reaffirmed its smoke-free policy for all NSW Health buildings, grounds and vehicles with the new NSW Health Smoke-free Health Care Policy. 1 Since 15 January 2015, all Local Health Districts (LHDs) are required to ensure compliance with the policy and have the power to enforce it with penalty infringement notices for smokers.
The policy outlines the responsibilities of all managers and staff. In particular, public hospital staff are required to undergo smoking cessation training and provide routine brief interventions to all smoking patients.
The new directive aims to deliver a consistent practice in all LHDs across New South Wales (NSW). Under the previous Smoke-free Workplace Policy, implementation of smoking restrictions has been patchy and has progressed slowly in some areas.
Although the prevalence of smoking is declining, 16.4% of NSW adults (aged ≥16 years) smoked in 2013, and rates are higher among hospitalised patients.2 Smoking remains the leading cause of preventable death and disability in NSW, accounting for around 5500 deaths and 46 000 hospitalisations each year.2
Being in hospital is a potentially powerful ‘teachable moment’ for change.3 Smokers in hospital are often motivated to quit due to concerns about their health, and most are receptive to smoking cessation advice from hospital staff.4 An absence of the normal smoking triggers, and access to health professionals for advice and support, can make quitting easier.
Long-term quit rates are significantly improved by brief hospital-based interventions.5 Smokers who quit have immediate and substantial health benefits6 , improved postoperative recovery7, reduced length of stay and lower readmission rates.5
Despite these potential benefits, most hospitalised smokers receive suboptimal smoking care.8 Inpatient interventions are delivered by busy clinicians in addition to their existing patient care responsibilities, and many do not feel that smoking cessation is part of their role.9 However, smoking cessation support is the responsibility of all hospital clinical staff, and effectiveness is improved if treatments are delivered by more than one health professional.
This paper will outline an evidence based and practical approach for use by clinical staff to assist hospitalised smokers, as required under the Smoke-free Health Care Policy. This includes a counselling framework and detailed advice about the use of nicotine replacement therapy (NRT). Drug interactions with smoking will also be discussed.
Multiple systemic strategies and organisational support are also required to optimise delivery of smoking cessation interventions, but are beyond the scope of this article.
Brief interventions delivered by hospital staff are effective. A Cochrane meta-analysis found that brief counselling that continued for at least 1 month after discharge increased quit rates by 37% at 6–12 months follow-up.5 Adding NRT to counselling increased cessation rates by a further 54%.5 This compares very favourably with unassisted quit attempts, which have a success rate of 3−5% after 6−12 months.10
Interventions for smokers having elective surgery can also be effective. A randomised controlled trial at a presurgical clinic at a NSW teaching hospital demonstrated significantly reduced preoperative smoking and increased quit rates after 3 months compared with usual care.11
Furthermore, hospital-based smoking cessation interventions are highly cost-effective, especially when compared with many other routine health interventions.12
All hospitalised smokers should be encouraged and assisted to quit permanently. A comprehensive, evidence based manual on how to manage nicotine dependence13 has recently been developed for NSW Health staff and is based on the ‘5As’ framework used in the Australian smoking cessation guidelines.14 The key steps of the 5As are listed below.
Ask all patients about smoking and record their smoking status in their medical record.
Assess smokers for their readiness to quit and the level of nicotine dependence.
Assess readiness to quit by asking, “How do you feel about your smoking?” Smokers thinking about quitting should be encouraged to try to quit for good.
The level of nicotine dependence helps predict the severity of withdrawal symptoms and is a guide to the intensity of treatment required. Ask the patient, “How long after you wake do you have your first cigarette?” Smoking within 30 minutes of waking is a reliable sign of nicotine dependence. Smoking within 5 minutes indicates high dependence.
All smokers should be informed of the hospital smoke-free policy and advised to quit in a clear, nonconfrontational, personalised way – for example, “The best thing you can do for your health/asthma/surgical risk is to stop smoking”.
All smokers should be offered help to quit, irrespective of their willingness to quit. The most effective way to quit smoking is with a combination of counselling and pharmacotherapy.
Counselling strategies for hospital patients include:14
NRT is recommended for all smokers who have nicotine dependence, and can be used to aid quitting or to support temporary abstinence.
Follow-up for at least 1 month after discharge is an essential ingredient for long-term success and should be arranged before discharge. Referral options include the patient’s general practitioner, Quitline (telephone 13 7848), a tobacco treatment specialist (see www.aascp.org.au) or a smoking clinic. Referrals to NSW Quitline can be made using its fax referral form.15 Interventions that do not include follow-up have been shown not to improve success rates.5 On discharge, all patients who have been using NRT should be provided with a minimum of 3 days’ medication. 1
Smokers who are not willing or ready to quit should be advised to quit and be supported through temporary abstinence in hospital. Most nicotine-dependent smokers will need NRT, because abrupt cessation can trigger nicotine withdrawal and cigarette cravings. Some of these smokers will go on to quit permanently, because a period of temporary abstinence in hospital can increase motivation and self-efficacy.16
NRT is the most appropriate medication in the hospital setting because of its quick action, safety, ease of use and proven efficacy.5 ,17 NRT should be offered to all nicotine-dependent smokers aged 12 and over soon after admission, to manage nicotine withdrawal symptoms and cigarette cravings (see Box 1). Symptoms appear within a few hours of the last cigarette and peak at 48−72 hours.
Box 1. Nicotine withdrawal symptoms
|
In most hospitals, NRT can be initiated by nursing staff with sign-off by a doctor within 24 hours. A range of NRT products should be available in the hospital dispensary to accommodate patient preferences and clinical suitability.
The nicotine patch is applied daily to the skin and provides continuous protection against background cravings. The oral forms (nicotine mouth spray, oral strips, lozenges, gum and inhalator) give faster, flexible relief for breakthrough (cue-induced) cravings as a result of smoking triggers, such as a cup of coffee (see Table 1).
Table 1. Nicotine replacement therapy
Product | Recommended dose | Course of treatment | Common adverse effects | Directions for use |
Nicotine patch 24 h: 21 mg, 14 mg, 7 mg16 h: 25 mg, 15 mg, 10 mg | Start with a full-strength patch if usually smoke >10 cigarettes per day | 12 weeks | Insomnia, disturbed dreams (24-h patch). Skin irritation | Apply in morning to upper arm, chest or back and rotate application site daily |
Nicotine mouth spray 1 mg per spray | 1−2 sprays every 30−60 min. Maximum 4 sprays per hour or 64 sprays per day | 12 weeks | Mouth/throat irritation, nausea, dyspepsia, headache, hiccups | Fast-acting craving relief. Spray under tongue or onto inside of cheek |
Nicotine oral strips 2.5 mg | Initially 1 strip every 1−2 h, up to 15 per day | 12 weeks | Nausea, throat irritation, hiccups, headache | Fast-acting craving relief for less dependent smokers (TTFC ≥ 30 min). Place on tongue and apply to palate. Dissolves in 2−3 min |
Nicotine lozenges 2 mg, 4 mg | 9−15 lozenges per day. Use 4 mg if TTFC < 30 min | 12 weeks | Nausea, hiccups, heartburn, flatulence | Allow to dissolve in mouth over 20−30 min, moving around from time to time |
Nicotine mini lozenges 1.5 mg, 4 mg | 1.5 mg: 9−20 per day 4 mg: 9−15 per day. Use 4 mg if TTFC < 30 min | 12 weeks | Nausea, hiccups, heartburn, flatulence | Allow to dissolve in mouth over 10−15 min, moving around from time to time |
Nicotine gum 2 mg, 4 mg | 2 mg: 8−20 per day 4 mg: 4−10 per day. Use 4 mg if TTFC < 30 min | 12 weeks | Hiccups, nausea, jaw discomfort, mouth/throat irritation | Instruct patients on ‘park and chew’ techniquea Avoid in people with dentures |
Nicotine inhalator 15 mg per cartridge | 3−6 cartridges per day | 12 weeks | Cough, mouth/throat irritation, nausea | Frequent, shallow puffs. Satisfies hand-to-mouth habit |
People who smoke more than 10 cigarettes per day and weigh more than 45 kg start with a full-strength patch (21 mg/24 hours or 25 mg/16 hours). An oral form of NRT is added if cravings or withdrawal symptoms are not controlled by the patch alone.14
Oral NRT products should be taken in anticipation of a smoking trigger if possible, or otherwise when cravings are experienced. The nicotine mouth spray and oral strips give the quickest relief. Oral NRT can also be used on a regular (e.g. hourly) basis.
NRT monotherapy (a single nicotine product) increases quit rates by 60% compared with placebo.17 Combination NRT (a nicotine patch plus an oral agent such as gum or lozenge) increases quit rates by a further 34% and is well tolerated.17
It is vital to instruct patients on the correct use of NRT products (see Table 1) because they are often used incorrectly.18 Nicotine from oral products is absorbed through the buccal mucosa and should not be swallowed or inhaled. Smokers should be advised not to drink or eat immediately before and while using any form of oral NRT because this reduces the absorption of nicotine.18
In general, patients using NRT receive too little nicotine to satisfy cravings, partly due to misguided concerns about safety, effectiveness and the risk of addiction. Blood nicotine levels from the recommended doses are about one-third to half those of regular smoking, so the initial dose can be safely increased if cravings are not controlled. Higher doses of the oral products have been shown to be safe and significantly increase quit rates.18 See Box 2 for a checklist for NRT prescribing.
Box 2. Checklist for prescribing NRT
Assess for nicotine dependence Check for:
Explain:
Start treatment:
|
Although nicotine is the main cause of dependence on tobacco, it has few significant adverse effects, except in pregnancy. Nicotine is absorbed more slowly from NRT than from smoking and reaches lower peak blood levels. NRT is always safer than smoking.
Adverse effects depend on the delivery system. The patch can cause skin irritation, disturbed sleep and abnormal dreams. The gum can cause jaw pain, and the inhalator and mouth spray can cause throat irritation. Other side-effects from oral treatments include dyspepsia, nausea and hiccups.
The safety of NRT in smokers with stable cardiovascular disease has been firmly established.19 There is also growing evidence for the safety of NRT in acute coronary syndromes, and its use in the hospital setting can be considered if patients are unable to abstain from smoking without it.19
There is no evidence to support the concern that NRT may impair postoperative wound healing. The current opinion is that the adverse effects of NRT on postoperative outcomes, if they exist, are minimal and harmless.20
There is insufficient evidence to determine whether NRT is safe in pregnancy, but available data and expert opinion suggest it is less harmful than continuing to smoke.21
Patients should be encouraged to quit smoking before hospital admission and in outpatient settings wherever possible. In these busy clinical settings, an ask-advise-refer protocol can be delivered in as little as 30 seconds. Where time permits, a recommendation for NRT may increase quit rates further.
Smoking should be addressed routinely at the time of booking or waitlisting for surgery. Surgery represents a teachable moment for quitting, especially when required for diseases related to smoking.22 However, very few surgical patients receive smoking cessation interventions preoperatively, and most smokers smoke up to the day of elective surgery.23 Smokers know little of their increased surgical risks, and many may quit with simple advice.23
A Cochrane meta-analysis found that intensive quitting interventions before surgery reduced postoperative complications by 42%.7 Cessation at least 4 weeks before elective surgery is recommended, but longer is better.7
Helping smokers to quit should also be a routine part of care in emergency departments and outpatient clinics.
Patients who smoke should be screened on admission for potential drug interactions with smoking. Tobacco smoke induces the activity of the hepatic enzyme CYP1A2, which metabolises a number of clinically important drugs (see Table 2).24 After smoking cessation, blood levels of these drugs rise within several days and dose reductions may be required.
Table 2. Clinically relevant drug interactions with smoking
Class | Medication | Clinical importance |
Antipsychotics | Clozapine, olanzapine | +++ |
Haloperidol, chlorpromazine, fluphenazine | + | |
Antidepressants | Fluvoxamine | ++ |
Duloxetine, mirtazapine, imipramine | + | |
Cardiovascular disease | Warfarin, Clopidogrel (significantly less effective after quitting) | +++ |
Beta-blockers, verapamil, flecainide | + | |
Other | Theophylline, insulin | +++ |
Benzodiazepines, naratriptan, ondansetron, some anticancer drugs | + | |
Lifestyle | Caffeine, alcohol | +++ |
Drugs with a narrow therapeutic range, such as clozapine and olanzapine, may require a dose reduction of up to 50% after quitting. Smokers taking warfarin require a 13% higher dose than nonsmokers, and close monitoring of the international normalised ratio is recommended after quitting. Caffeine intake should be reduced by half to lessen the risk of caffeine toxicity. In contrast, clopidogrel is less effective after quitting (‘the smoker’s paradox’).
A more comprehensive list of drug interactions is available online.25
Hospitalisation is a powerful teachable moment for change. All patients should be asked about smoking on admission, and smokers should be encouraged and assisted to quit permanently. The most effective interventions include a combination of counselling and NRT.
Brief interventions that include at least 4 weeks follow-up after discharge from hospital significantly increase long-term quit rates.
Smoking cessation interventions are the responsibility of all medical, nursing and allied health staff in hospitals and should be integrated into routine clinical practice.
Copyright:
© 2015 Mendelsohn. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Licence, which allows others to redistribute, adapt and share this work non-commercially provided they attribute the work and any adapted version of it is distributed under the same Creative Commons licence terms.